Fate Therapeutics FATE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.98 | 107.25 | -0.27 | -34,721 | -32 | |
| 2025Q3 | 1.26 | 107.71 | -0.27 | -34,735 | -32 | |
| 2025Q2 | 1.12 | 108.51 | -0.29 | -36,968 | -34 | |
| 2025Q1 | 0.79 | 109.73 | -0.32 | -41,280 | -38 | |
| 2024Q4 | 1.65 | 118.40 | -0.45 | -61,748 | -52 | |
| 2024Q3 | 3.50 | 109.86 | -0.40 | -52,377 | -48 | |
| 2024Q2 | 3.28 | 117.32 | -0.32 | -45,083 | -38 | |
| 2024Q1 | 7.34 | 106.38 | -0.47 | -51,068 | -48 | |
| 2023Q4 | 3.74 | 108.96 | -0.45 | -48,075 | -44 | |
| 2023Q3 | 2.12 | 113.52 | -0.46 | -51,279 | -45 | |
| 2023Q2 | 4.76 | 118.60 | -0.54 | -62,565 | -53 | |
| 2023Q1 | 5.70 | 151.43 | -0.19 | -28,592 | -19 | |
| 2022Q4 | 10.09 | 114.29 | -0.58 | -64,419 | -56 | |
| 2022Q3 | 22.41 | 103.38 | -0.86 | -86,391 | -84 | |
| 2022Q2 | 24.78 | 109.20 | -0.79 | -83,109 | -76 | |
| 2022Q1 | 38.77 | 113.36 | -0.68 | -74,467 | -66 | |
| 2021Q4 | 58.51 | 101.11 | -0.72 | -69,382 | -69 | |
| 2021Q3 | 59.27 | 126.13 | -0.45 | -54,623 | -43 | |
| 2021Q2 | 86.79 | 84.85 | -0.59 | -46,779 | -55 | |
| 2021Q1 | 82.45 | 102.49 | -0.48 | -46,210 | -45 |